About Algorithme Pharma
Algorithme Pharma is a company based in Montreal (Canada) founded in 1992 was acquired by Kilmer Group in October 2007. Algorithme Pharma offers products and services including Preclinical Services, Clinical Services, Bioanalysis Services, and Manufacturing Services. Algorithme Pharma operates in a competitive market with competitors including Celerion, Altasciences, Ask Gene Pharma, iCardiac Technologies and Open Orphan, among others.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Kilmer Group
(Oct 17, 2007)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Algorithme Pharma
Algorithme Pharma offers a comprehensive portfolio of products and services, including Preclinical Services, Clinical Services, Bioanalysis Services, and Manufacturing Services.
Conducts safety evaluations for small and large molecules in preclinical stages.
Performs clinical trials from first-in-human to Phase II studies.
Offers bioanalytical testing for preclinical to Phase IV drug development.
Provides formulation development and stability testing for drugs.
Funding Insights of Algorithme Pharma
Detailed funding history for Algorithme Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Algorithme Pharma
Algorithme Pharma has secured backing from 1 investor. Prominent investors backing the company include Kilmer Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A multi-generational platform for business development and investment is provided.
|
Locked | Locked | Locked |
Investor details for Algorithme Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Algorithme Pharma
Investment portfolio details for Algorithme Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Algorithme Pharma
Detailed financials for Algorithme Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Algorithme Pharma Comparisons
Peer comparison for Algorithme Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Algorithme Pharma
Algorithme Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celerion, Altasciences, Ask Gene Pharma, iCardiac Technologies and Open Orphan, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Early clinical research services are provided for drug development.
|
|
| Locked | Locked | Locked |
Early phase clinical research services are provided in North America.
|
|
| Locked | Locked | Locked |
Biosimilars and biosuperiors are developed and commercialized in biotechnology.
|
|
| Locked | Locked | Locked |
Cardiac safety testing and respiratory laboratory services are provided.
|
|
| Locked | Locked | Locked |
Provider of testing vaccines & antivirals and CRO pharmaceutical services
|
|
| Locked | Locked | Locked |
CRO focused on early stage clinical trial research
|
Detailed competitors of Algorithme Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Algorithme Pharma
Complete news archive for Algorithme Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Algorithme Pharma
Algorithme Pharma was founded in 1992.
Algorithme Pharma is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Algorithme Pharma is an early stage full-service CRO offering its services to the pharmaceutical, biotechnology and generic drug industries. They are part of Altasciences, an early stage North American CRO and have operations both in Canada and the US. The company claims to have conducted over 5500 trials since its inception in 1992. Their clinical trial services portfolio includes large and small molecule bioanalysis, data management, biostatistics, regulatory support, clinical pharmacology and project management. Founded by pharmacology researchers from the University of Montreal, the company annually conducts over 200 Phase IIIa, Bioequivalence and Bioanalysis (preclinical to Phase I-IV) trials. They claim to have access to a patient database with 120000 patients, out of which 40,000 are active. They conduct clinical trials for clients who are all over the world. The company had entered into a partnership with Kilmer Capital Partners, a Canadian investment group in 2007.
Algorithme Pharma's top competitors include Celerion, Ask Gene Pharma and Altasciences.
Algorithme Pharma offers Preclinical Services, Clinical Services, Bioanalysis Services, and Manufacturing Services.
Algorithme Pharma has 1 investor. Key investors include Kilmer Group.